SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (393)1/9/1999 11:38:00 PM
From: Edward W. Richmond  Read Replies (1) | Respond to of 1321
 
I was impressed with both the interview and the Post article. Monday should be interesting. Any predictions on what direction and by how much the stock will move at the close of trading? Remember, the US investors have a major influence on the stock price.
I predict a +$0.60 move on the TSE at Monday's close.
Regards, Ed



To: Ian@SI who wrote (393)1/10/1999 7:32:00 PM
From: Zeev Hed  Read Replies (1) | Respond to of 1321
 
Ian, actually, in the health care field, it is typically safe to assume "the rest of the world" at the same number (that is the factor I have been using in a large number of "business plans" for medical instrumentation system for years) as the total in the US (I should say expected use not "head count of potential patients) and this is indeed related to less intensive medicine in the rest of the world. For AMD that might be somewhat different and thus Julia's 2.5 number could be rational, and possibly a little optimistic.

Zeev